Works in American Journal of Hematology, 2023, Vol 98, Issue 1

Results: 30
    1
    2
    3
    4
    5
    6
    7

    Predictors of impaired antibody response after SARS‐CoV‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 102, doi. 10.1002/ajh.26769
    By:
    • Mori, Yasuo;
    • Uchida, Naoyuki;
    • Harada, Takuya;
    • Katayama, Yuta;
    • Wake, Atsushi;
    • Iwasaki, Hiromi;
    • Eto, Tetsuya;
    • Morishige, Satoshi;
    • Fujisaki, Tomoaki;
    • Ito, Yoshikiyo;
    • Kamimura, Tomohiko;
    • Takahashi, Tsutomu;
    • Imamura, Yutaka;
    • Tanimoto, Kazushi;
    • Ishitsuka, Kenji;
    • Sugita, Junichi;
    • Kawano, Noriaki;
    • Tanimoto, Kazuki;
    • Yoshimoto, Goichi;
    • Choi, Ilseung
    Publication type:
    Article
    8
    9
    10

    Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 112, doi. 10.1002/ajh.26764
    By:
    • Chalandon, Yves;
    • Sbianchi, Giulia;
    • Gras, Luuk;
    • Koster, Linda;
    • Apperley, Jane;
    • Byrne, Jenny;
    • Salmenniemi, Urpu;
    • Sengeloev, Henrik;
    • Aljurf, Mahmoud;
    • Helbig, Grzegorz;
    • Kinsella, Francesca;
    • Choi, Goda;
    • Reményi, Péter;
    • Snowden, John A.;
    • Robin, Marie;
    • Lenhoff, Stig;
    • Mielke, Stephan;
    • Passweg, Jakob;
    • Broers, Annoek E. C.;
    • Kröger, Nicolaus
    Publication type:
    Article
    11

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    12
    13
    14

    Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 66, doi. 10.1002/ajh.26758
    By:
    • Wang, Qian;
    • Cai, Wen‐zhi;
    • Wang, Qin‐rong;
    • Zhu, Ming‐qing;
    • Yan, Ling‐zhi;
    • Yu, Yan;
    • Bao, Xie‐bing;
    • Shen, Hong‐jie;
    • Yao, Hong;
    • Xie, Jun‐dan;
    • Zhang, Tong‐tong;
    • Zhang, Ling;
    • Xu, Xiao‐yu;
    • Shan, Zhe;
    • Liu, Hong;
    • Cen, Jian‐nong;
    • Liu, Dan‐dan;
    • Pan, Jin‐lan;
    • Lu, Da‐ru;
    • Chen, Jia
    Publication type:
    Article
    15

    Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 79, doi. 10.1002/ajh.26757
    By:
    • Stahl, Maximilian;
    • Derkach, Andriy;
    • Farnoud, Noushin;
    • Bewersdorf, Jan Philipp;
    • Robinson, Troy;
    • Famulare, Christopher;
    • Cho, Christina;
    • Devlin, Sean;
    • Menghrajani, Kamal;
    • Patel, Minal A.;
    • Cai, Sheng F.;
    • Miles, Linde A.;
    • Bowman, Robert L.;
    • Geyer, Mark B.;
    • Dunbar, Andrew;
    • Epstein‐Peterson, Zachary D.;
    • McGovern, Erin;
    • Schulman, Jessica;
    • Glass, Jacob L.;
    • Taylor, Justin
    Publication type:
    Article
    16
    17
    18
    19
    20

    Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 11, doi. 10.1002/ajh.26741
    By:
    • Kanter, Julie;
    • Thompson, Alexis A.;
    • Pierciey, Francis J.;
    • Hsieh, Matthew;
    • Uchida, Naoya;
    • Leboulch, Philippe;
    • Schmidt, Manfred;
    • Bonner, Melissa;
    • Guo, Ruiting;
    • Miller, Alex;
    • Ribeil, Jean‐Antoine;
    • Davidson, David;
    • Asmal, Mohammed;
    • Walters, Mark C.;
    • Tisdale, John F.
    Publication type:
    Article
    21

    Granular B lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 210, doi. 10.1002/ajh.26674
    By:
    • Hazarika, Biswadip;
    • Bain, Barbara J.
    Publication type:
    Article
    22

    Neutrophil‐Erythrocyte Rosettes in COVID‐19.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 220, doi. 10.1002/ajh.26637
    By:
    • Fan, Bingwen Eugene;
    • Leong, Jia Qi Wendy;
    • Leung, Bernard Pui Lam;
    • Ng, Weng Yik;
    • Lim, Wendy Siew Lian;
    • Wong, Wei Yong Kevin;
    • Lim, Wei Yin;
    • Chen, Siew Ping Connie;
    • Yap, Sheem Ying Rachel;
    • Tan, Guat Bee;
    • Chow, Minyang;
    • Mucheli, Sharavan Sadasiv;
    • Kuperan, Ponnudurai;
    • Gallardo, Christian Aledia
    Publication type:
    Article
    23

    Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. E11, doi. 10.1002/ajh.26622
    By:
    • Paul, Shilpa;
    • Kantarjian, Hagop;
    • Sasaki, Koji;
    • Marx, Kayleigh;
    • Jain, Nitin;
    • Savoy, J. Michael;
    • DiPippo, Adam;
    • Jammal, Nadya;
    • Bravo, Guillermo Montalban;
    • Kadia, Tapan;
    • Garcia‐Manero, Guillermo;
    • Short, Nicholas J.;
    • Ravandi, Farhad;
    • Jabbour, Elias
    Publication type:
    Article
    24

    Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 131, doi. 10.1002/ajh.26619
    By:
    • Beaton, Brendan;
    • Sasson, Sarah C.;
    • Rankin, Katherine;
    • Raedemaeker, Juliette;
    • Wong, Alexander;
    • Hastak, Priyanka;
    • Phetsouphanh, Chansavath;
    • Warden, Andrew;
    • Klemm, Vera;
    • Munier, C. Mee Ling;
    • Hoppe, Alexandra Carey;
    • Tea, Fiona;
    • Pillay, Aleha;
    • Stella, Alberto Ospina;
    • Aggarwal, Anupriya;
    • Lavee, Orly;
    • Caterson, Ian D.;
    • Turville, Stuart;
    • Kelleher, Anthony D.;
    • Brilot, Fabienne
    Publication type:
    Article
    25

    Issue Information.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 1, doi. 10.1002/ajh.26840
    Publication type:
    Article
    26

    Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. E15, doi. 10.1002/ajh.26602
    By:
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Augustson, Bradley;
    • Castro, Nelson;
    • Pika, Tomas;
    • Delimpasi, Sosana;
    • De la Rubia, Javier;
    • Maiolino, Angelo;
    • Reiman, Tony;
    • Martinez‐Lopez, Joaquin;
    • Martin, Thomas;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Risse, Marie‐Laure;
    • Asset, Gaelle;
    • Marion, Sylvia;
    • Hajek, Roman
    Publication type:
    Article
    27

    Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
    By:
    • D'Souza, Anita;
    • Brazauskas, Ruta;
    • Stadtmauer, Edward A.;
    • Pasquini, Marcelo C.;
    • Hari, Parameswaran;
    • Bashey, Asad;
    • Callander, Natalie;
    • Devine, Steven;
    • Efebera, Yvonne;
    • Ganguly, Siddhartha;
    • Gasparetto, Cristina;
    • Geller, Nancy;
    • Horowitz, Mary M.;
    • Koreth, John;
    • Landau, Heather;
    • Brunstein, Claudio;
    • McCarthy, Philip;
    • Qazilbash, Muzaffar H.;
    • Giralt, Sergio;
    • Krishnan, Amrita
    Publication type:
    Article
    28

    Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 159, doi. 10.1002/ajh.26594
    By:
    • Gottlieb, David J.;
    • Sutrave, Gaurav;
    • Jiang, Wei;
    • Avdic, Selmir;
    • Street, Janine A.;
    • Simms, Renee;
    • Clancy, Leighton E.;
    • Antonenas, Vicki;
    • Gloss, Brian S.;
    • Bateman, Caroline;
    • Bishop, David C.;
    • Micklethwaite, Kenneth P.;
    • Blyth, Emily
    Publication type:
    Article
    29
    30